pramlintide glp 1 Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity | Diabetes Therapy Amylin: From Mode of Action
Description
After years of fighting over compounded weight loss drugs, Hims & Hers and Novo Nordisk are teaming up to sell Ozempic and Wegovy a shift that could raise costs for patients.
Unlike FDA-approved medications (e.g., Wegovy, Ozempic, Zepbound), compounded alternatives lack agency review for safety, quality, and efficacy
GLP-1 RAs have been used for diabetes and found to improve CV outcomes in diabetic and nondiabetic patients
This suggests that the GLP-1R KO mouse model may serve as a model for correlated metabolic and functional connectivity loss.
